FDA Approves First Drug Doubling Pancreatic Cancer Survival

A groundbreaking new pill has been approved to treat pancreatic cancer, doubling survival time compared to chemotherapy and targeting the mutations found in over 90% of cases.

For decades, these mutations were considered impossible to treat.